Home Response to growth hormone treatment in very young patients with growth hormone deficiencies and mini-puberty
Article
Licensed
Unlicensed Requires Authentication

Response to growth hormone treatment in very young patients with growth hormone deficiencies and mini-puberty

  • Semra Çetinkaya EMAIL logo , Şükran Poyrazoğlu , Firdevs Baş , Oya Ercan , Metin Yıldız , Erdal Adal , Abdullah Bereket , Saygın Abalı , Zehra Aycan , Şenay Savaş Erdeve , Merih Berberoğlu , Zeynep Şıklar , Meltem Tayfun , Şükran Darcan , Eda Mengen , İffet Bircan , Filiz Mine Çizmecioğlu Jones , Enver Şimşek , Esra Deniz Papatya , Mehmet Nuri Özbek , Semih Bolu , Ayhan Abacı , Muammer Büyükinan and Feyza Darendeliler
Published/Copyright: January 20, 2018

Abstract

Background:

The aim of the study was to assess the response to growth hormone (GH) treatment in very young patients with GH deficiency (GHD) through a national, multi-center study. Possible factors affecting growth response were assessed (especially mini-puberty).

Methods:

Medical reports of GHD patients in whom treatment was initiated between 0 and 3 years of age were retrospectively evaluated.

Results:

The cohort numbered 67. The diagnosis age was 12.4±8.6 months, peak GH stimulation test response (at diagnosis) as 1.0±1.4 ng/mL. The first and second years length gain was 15.0±4.3 and 10.4±3.4 cm. Weight gain had the largest effect on first year growth response; whereas weight gain and GH dose were both important factors affecting second year growth response. In the multiple pituitary hormone deficiency (MPHD) group (n=50), first year GH response was significantly greater than in the isolated GH deficiency (IGHD) group (n=17) (p=0.030). In addition first year growth response of infants starting GH between 0 and 12 months of age (n=24) was significantly greater than those who started treatment between 12 and 36 months of age (n=43) (p<0.001). These differences were not seen in the second year. Δ Length/height standard deviation score (SDS), Δ body weight SDS, length/height SDS, weight SDS in MPHD without hypogonadism for the first year of the GH treatment were found as significantly better than MPHD with hypogonadism.

Conclusions:

Early onsets of GH treatment, good weight gain in the first year of the treatment and good weight gain-GH dose in the second year of the treatment are the factors that have the greatest effect on length gain in early onset GHD. The presence of the sex steroid hormones during minipubertal period influence growth pattern positively under GH treatment (closer to the normal percentage according to age and gender).


Corresponding author: Prof. Semra Çetinkaya, Health Sciences University, Dr Sami Ulus Obstetrics and Gynecology, Children’s Health and Disease, Health Implementation and Research Center, Department of Pediatric Endocrinology, Ankara, Turkey, Phone: +90 505 388 44 03

Acknowledgments

For technical support, we would like to thank the ÇEDD-NET Web Registry System and its staff, as well as the Turkish Society of Endocrinology and Diabetes.

  1. Author contributions: S. Cetinkaya, F. Darendeliler: Concept, design, analysis, interpretation of data, writing the manuscript or revising it critically for content, S. Poyrazoglu, F. Baş, O. Ercan, M. Yıldız, E. Adal, A. Bereket, S. Abalı, Z. Aycan, Ş. Savaş Erdeve, M. Berberoglu, Z. Sıklar, M. Tayfun, Ş. Darcan, E. Mengen, İ. Bircan, F. M. Çizmecioğlu Jones, E. Şimşek, E. D. Papatya, M. N. Özbek, S. Bolu, A. Abacı, M. Büyükinan: Interpretation of data. All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: This work was supported by the Turkish Pediatric Endocrinology and Diabetes Society (Grant Number: 022014).

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Karlberg J, Albertsson-Wikland K. Infancy growth pattern related to growth hormone deficiency. Acta Paediatr Scand 1988;77: 385–91.10.1111/j.1651-2227.1988.tb10665.xSearch in Google Scholar

2. Karlberg JA. Biologically-oriented mathematical model (ICP) for human growth. Acta Paediatr Scand 1989;350(Suppl):70–94.10.1111/j.1651-2227.1989.tb11199.xSearch in Google Scholar

3. Arrigo T, De Luca F, Bernasconi S, Bozzola M, Cavallo L, et al. Catch-up growth and height prognosis in early treated children with congenital hypopituitarism. Horm Res 1995;44(Suppl 3):26–31.10.1159/000184670Search in Google Scholar

4. Argente J, Abusrewil SA, Bona G, Chiarelli F, Kelnar CJ, et al. Isolated growth hormone deficiency in children and adolescents. J Pediatr Endocrinol Metab 2001;14(Suppl 2):1003–8.10.1515/jpem-2001-s213Search in Google Scholar

5. Binder G, Weidenkeller M, Blumenstock G, Langkamp M, Weber K, et al. Rational approach to the diagnosis of severe growth hormone deficiency in the newborn. J Clin Endocrinol Metab 2010;95:2219–26.10.1210/endo-meetings.2010.PART3.P14.P3-685Search in Google Scholar

6. Achermann JC, Hughes IA. Disorders of sex development. In: Kronenberg HM, Melmed S, Polonsky KS, Larsen PR, editors. Williams textbook of endocrinology, 12th ed. Philadelphia, PA: Saunders Elsevier, 2011:863–94.Search in Google Scholar

7. Kiviranta P, Kuiri-Hänninen T, Saari A, Lamidi ML, Dunkel L, et al. Transient postnatal gonadal activation and growth velocity in infancy. Pediatrics 2016;138:pii: e20153561. doi: 10.1542/peds.2015-3561.10.1542/peds.2015-3561Search in Google Scholar

8. Grumbach MM, Bin-Abbas BS, Kaplan SL. The growth hormone cascade: progress and long-term results of growth hormone treatment in growth hormone deficiency. Horm Res 1998;49(Suppl 2):41–57.10.1159/000053087Search in Google Scholar

9. De Luca F, Arrigo T, Bozzola M, Crisafulli G, Ghizzoni L, et al. Hypopituitarism during the first year of life. A collaborative Italian study. Arch Pediatr 1998;5(Suppl 4):313–7.10.1016/S0929-693X(99)80182-1Search in Google Scholar

10. Arrigo T, Bozzola M, Cavallo L, Ghizzoni L, Maghnie M, et al. Growth hormone deficient children treated from before two years old fail to catch-up completely within five years of treatment. J Pediatr Endocrinol Metab 1998;11:45–50.10.1515/JPEM.1998.11.1.45Search in Google Scholar PubMed

11. Wasniewska M, Arrigo T, Cisternino M, De Luca F, Ghizzoni L, et al. Birth weight influences long-term catch-up growth and height prognosis of GH-deficient children treated before the age of 2 years. Eur J Endocrinol 2000;142:460–5.10.1530/eje.0.1420460Search in Google Scholar PubMed

12. Achermann JC, Hamdani K, Hindmarsh PC, Brook CG. Birth weight influences the initial response to growth hormone treatment in growth hormone-insufficient children. Pediatrics 1998;102(2 Pt 1):342–5.10.1542/peds.102.2.342Search in Google Scholar

13. Breier BH, Gluckman PD. The regulation of postnatal growth: nutritional influences on endocrine pathways and function of the somatotrophic axis. Livest Prod Sci 1991;27;77–94.10.1016/0301-6226(91)90047-TSearch in Google Scholar

14. Boersma B, Rikken B, Wit JM. Catch-up growth in early treated patients with growth hormone deficiency. Dutch Growth Hormone Working Group. Arch Dis Child 1995;72:427–31.10.1136/adc.72.5.427Search in Google Scholar PubMed PubMed Central

15. Ranke MB, Lindberg A, Albertsson-Wikland K, Wilton P, Price DA, et al. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0–3 years) with idiopathic GH deficiency: analysis of data from KIGS. J Clin Endocrinol Metab 2005;90:1966–71.10.1210/jc.2004-1051Search in Google Scholar PubMed

16. Root AW, Dana K, Lippe B. Treatment of growth hormone-deficient infants with recombinant human growth hormone to near-adult height: patterns of growth. Horm Res Paediatr 2011;75:276–83.10.1159/000322881Search in Google Scholar PubMed

17. Huet F, Carel JC, Nivelon JL, Chaussain JL. Long-term results of GH treatment in GH-deficient children treated before 1 year of age. Eur J Endocrinol 1999;140:29–34.10.1530/eje.0.1400029Search in Google Scholar PubMed

18. Rappaport R, Mugnier E, Limoni C, Crosnier H, Czernichow P, et al. A 5-year prospective study of growth hormone (GH)-deficient children treated with GH before the age of 3 years. J Clin Endocrinol Metab 1997;82:452–6.10.1210/jc.82.2.452Search in Google Scholar

Received: 2017-3-29
Accepted: 2017-11-28
Published Online: 2018-1-20
Published in Print: 2018-1-26

©2018 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Review
  3. The role of corticosteroid-binding globulin in the evaluation of adrenal insufficiency
  4. Original Articles
  5. Association of sodium intake with insulin resistance in Korean children and adolescents: the Korea National Health and Nutrition Examination Survey 2010
  6. Decrease in serum chemerin through aerobic exercise plus dieting and its association with mitigation of cardio-metabolic risk in obese female adolescents
  7. Ultrasonographic assessment of pubertal breast development in obese children: compliance with the clinic
  8. Associations of leptin, insulin and lipids with retinal microvasculature in children and adolescents
  9. Association of cord blood ghrelin, leptin and insulin concentrations in term newborns with anthropometric parameters at birth
  10. Management of thyrotoxicosis in children and adolescents: 35 years’ experience in 304 patients
  11. Clinical and cytogenetic features of 516 patients with suspected Turner syndrome – a single-center experience
  12. Response to growth hormone treatment in very young patients with growth hormone deficiencies and mini-puberty
  13. Reference centile curves for wrist circumference for Indian children aged 3–18 years
  14. Comparison between two inhibin B ELISA assays in 46,XY testicular disorders of sex development (DSD) with normal testosterone secretion
  15. Genetic mutations associated with neonatal diabetes mellitus in Omani patients
  16. Four novel mutations of the BCKDHA, BCKDHB and DBT genes in Iranian patients with maple syrup urine disease
  17. Improved medical-alert ID ownership and utilization in youth with congenital adrenal hyperplasia following a parent educational intervention
  18. Letter to the Editor
  19. Identification of five mutations in a patient with galactose metabolic disorders
  20. Case Reports
  21. Partial androgen insensitivity syndrome due to somatic mosaicism of the androgen receptor
  22. Vaginal bleeding and a giant ovarian cyst in an infant with 21-hydroxylase deficiency
  23. Insulin-mediated pseudoacromegaly: a report of two pediatric patients
  24. Novel compound heterozygous variants in the LHCGR gene identified in a subject with Leydig cell hypoplasia type 1
Downloaded on 28.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2017-0123/pdf
Scroll to top button